Sichuan Hebang Biotechnology Corporation Statistics

Total Valuation

Sichuan Hebang Biotechnology Corporation has a market cap or net worth of CNY 17.09 billion. The enterprise value is 18.58 billion.

Market Cap	17.09B
Enterprise Value	18.58B

Important Dates

The last earnings date was Monday, October 21, 2024.

Earnings Date	Oct 21, 2024
Ex-Dividend Date	Oct 15, 2024

Share Statistics

Sichuan Hebang Biotechnology Corporation has 8.03 billion shares outstanding. The number of shares has decreased by -4.23% in one year.

Current Share Class	n/a
Shares Outstanding	8.03B
Shares Change (YoY)	-4.23%
Shares Change (QoQ)	-2.91%
Owned by Insiders (%)	5.96%
Owned by Institutions (%)	4.92%
Float	4.68B

Valuation Ratios

The trailing PE ratio is 36.66.

PE Ratio	36.66
Forward PE	n/a
PS Ratio	1.93
PB Ratio	0.91
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.45, with an EV/FCF ratio of -19.93.

EV / Earnings	38.28
EV / Sales	2.02
EV / EBITDA	11.45
EV / EBIT	32.87
EV / FCF	-19.93

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.18.

Current Ratio	1.88
Quick Ratio	0.95
Debt / Equity	0.18
Debt / EBITDA	2.12
Debt / FCF	-3.69
Interest Coverage	13.23

Financial Efficiency

Return on equity (ROE) is 2.31% and return on invested capital (ROIC) is 1.56%.

Return on Equity (ROE)	2.31%
Return on Assets (ROA)	1.39%
Return on Capital (ROIC)	1.56%
Revenue Per Employee	1.28M
Profits Per Employee	67,725
Employee Count	7,169
Asset Turnover	0.36
Inventory Turnover	1.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.17% in the last 52 weeks. The beta is 0.32, so Sichuan Hebang Biotechnology Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-7.17%
50-Day Moving Average	1.91
200-Day Moving Average	2.02
Relative Strength Index (RSI)	58.97
Average Volume (20 Days)	162,991,949

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sichuan Hebang Biotechnology Corporation had revenue of CNY 9.20 billion and earned 485.52 million in profits. Earnings per share was 0.06.

Revenue	9.20B
Gross Profit	1.18B
Operating Income	565.37M
Pretax Income	585.63M
Net Income	485.52M
EBITDA	1.61B
EBIT	565.37M
Earnings Per Share (EPS)	0.06

Full Income Statement

Balance Sheet

The company has 2.57 billion in cash and 3.44 billion in debt, giving a net cash position of -873.33 million or -0.11 per share.

Cash & Cash Equivalents	2.57B
Total Debt	3.44B
Net Cash	-873.33M
Net Cash Per Share	-0.11
Equity (Book Value)	19.38B
Book Value Per Share	2.34
Working Capital	5.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -204.59 million and capital expenditures -728.02 million, giving a free cash flow of -932.60 million.

Operating Cash Flow	-204.59M
Capital Expenditures	-728.02M
Free Cash Flow	-932.60M
FCF Per Share	-0.12

Full Cash Flow Statement

Margins

Gross margin is 12.84%, with operating and profit margins of 6.14% and 5.28%.

Gross Margin	12.84%
Operating Margin	6.14%
Pretax Margin	6.36%
Profit Margin	5.28%
EBITDA Margin	17.48%
EBIT Margin	6.14%
FCF Margin	-10.13%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.87%.

Dividend Per Share	0.04
Dividend Yield	1.87%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	17.19%
Buyback Yield	4.23%
Shareholder Yield	6.10%
Earnings Yield	2.73%
FCF Yield	-5.46%

Dividend Details

Stock Splits

The last stock split was on July 5, 2017. It was a forward split with a ratio of 2.2.

Last Split Date	Jul 5, 2017
Split Type	Forward
Split Ratio	2.2

Scores

Sichuan Hebang Biotechnology Corporation has an Altman Z-Score of 2.85. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.85
Piotroski F-Score	n/a